May 2, 2025 06:52 AM EDTUpdated 07:55 AM
R&D
Manufacturing

In­vestors un­veil plans for $1.3B can­cer hub in Lon­don sub­urbs

Ayisha Sharma

News Reporter

Avi­va Cap­i­tal Part­ners and de­vel­op­ment com­pa­ny So­cius are plan­ning a new £1 bil­lion ($1.3 bil­lion) hub ded­i­cat­ed to can­cer re­search in the town of Sut­ton …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: Ver­tex drops AAV gene ther­a­py re­search, tR­NA ther­a­py part­ner­ship

Drug­mak­ers ex­ploit can­cer’s ‘lethal­i­ties’ to make next class of tar­get­ed ther­a­pies, with first re­sults for ...

Ex­clu­sive: Af­ter FDA fir­ings, drug re­view­ers are asked to vol­un­teer for ad­min­is­tra­tive work

Feng Zhang’s pro­tein nanopar­ti­cle start­up Aera Ther­a­peu­tics turns to lipid nanopar­ti­cles to jump­start its pipeline

The in­side sto­ry of how Sali­o­Gen, a start­up try­ing to wran­gle ‘jump­ing genes’ to make med­i­cines, fell apart

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times